Nunes, Marielza Andrade; Toricelli, Mariana 
; Schöwe, Natália Mendes; Malerba, Helena Nascimento; Dong, Karis Ester; Farah, Daniela Moura Azevedo Tuma ; De Angelis, Kátia; Irigoyen, Maria Claudia Costa ; Gobeil, Fernand; Viel, Tania Araujo ; Buck, Hudson Sousa
Fonte: Pharmaceuticals. Unidades: FM, EACH
Assuntos: DOENÇA DE ALZHEIMER, BRADICININA, DOENÇAS NEURODEGENERATIVAS, RECEPTORES COLINÉRGICOS, MEMÓRIA, EXPERIMENTOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Marielza Andrade et al. Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model. Pharmaceuticals, v. 13, n. 10, p. 01-16, 2020Tradução . . Disponível em: https://doi.org/10.3390/ph13100288. Acesso em: 16 maio 2024.APA
Nunes, M. A., Toricelli, M., Schöwe, N. M., Malerba, H. N., Dong, K. E., Farah, D. M. A. T., et al. (2020). Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model. Pharmaceuticals, 13( 10), 01-16. doi:10.3390/ph13100288NLM
Nunes MA, Toricelli M, Schöwe NM, Malerba HN, Dong KE, Farah DMAT, De Angelis K, Irigoyen MCC, Gobeil F, Viel TA, Buck HS. Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model [Internet]. Pharmaceuticals. 2020 ; 13( 10): 01-16.[citado 2024 maio 16 ] Available from: https://doi.org/10.3390/ph13100288Vancouver
Nunes MA, Toricelli M, Schöwe NM, Malerba HN, Dong KE, Farah DMAT, De Angelis K, Irigoyen MCC, Gobeil F, Viel TA, Buck HS. Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model [Internet]. Pharmaceuticals. 2020 ; 13( 10): 01-16.[citado 2024 maio 16 ] Available from: https://doi.org/10.3390/ph13100288
